Interfrin

Oxymetazoline Hydrochloride, the active ingredient in Interfrin, is an alpha‑adrenergic agonist presented as a nasal spray for nasal use. It provides rapid relief of nasal congestion caused by colds, sinusitis and allergic rhinitis. GNH USA supplies Interfrin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Interfrin, an alpha‑adrenergic nasal decongestant, is used to alleviate congestion in several common upper‑respiratory conditions.

Nasal congestion due to common cold: reduces swelling of nasal mucosa for quick airway opening. Sinusitis‑related congestion: eases blockage by constricting dilated blood vessels. Allergic rhinitis: diminishes nasal stuffiness associated with allergic inflammation.

Oxymetazoline Hydrochloride may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Nasal irritation or burning sensation - Dryness of the nasal mucosa - Sneezing - Mild headache - Transient epistaxis (nosebleed) - Unpleasant taste

Serious or Rare Side Effects: - Severe hypertension or hypertensive crisis - Tachycardia or arrhythmias - Ischemic events (e.g., myocardial infarction) - Allergic reactions including anaphylaxis - Rebound congestion (rhinitis medicamentosa) with prolonged use - Nasal ulceration or perforation in extreme cases

When using Interfrin, certain precautions should be observed to minimize risks.

Do not exceed recommended duration: limit use to three consecutive days to avoid rebound congestion. Avoid use in patients with severe hypertension: consult a physician before administration. Use with caution in cardiovascular disease: monitor blood pressure and heart rate. Pregnant or breastfeeding women: seek medical advice prior to use. Children under the recommended age: not advised unless directed by a healthcare professional. Store at room temperature: keep in the original container, protect from moisture and heat.

Oxymetazoline may interact with other medicines, requiring attention to avoid adverse effects.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): risk of additive hypertensive response. - Concurrent use of other nasal decongestants: may cause excessive vasoconstriction.

Moderate Interactions (Monitor Closely): - Antihypertensive agents: possible reduction in blood‑pressure‑lowering effect. - Tricyclic antidepressants: may potentiate pressor response. - Beta‑blockers: monitor for changes in heart rate and blood pressure. - Sympathomimetic drugs (e.g., ephedrine): increased cardiovascular stimulation risk.